BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
0.9639
-0.0961 (-9.07%)
At close: Nov 20, 2026, 4:00 PM EST
0.9900
+0.0261 (2.71%)
After-hours: Nov 20, 2026, 7:30 PM EST
BioLineRx Stock Forecast
BLRX's stock price has decreased by -71.05% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, BioLineRx stock has an average price target of $22. The average 1-year stock price forecast is 2,182.39% higher than the current stock price, while the lowest is $18 (+1,767.41%) and the highest is $26 (+2,597.38%).
Price Target: $22 (+2,182.39%)
Analyst Consensus: n/a
Price Target
Chart* Price targets were last updated on Oct 23, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for BioLineRx is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 0 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $26 | Buy | Maintains | $26 | +2,597.38% | Oct 23, 2026 |
Financial Forecast
Revenue This Year
1.62M
from 1.18M
Increased by 37.33%
Revenue Next Year
2.22M
from 1.62M
Increased by 37.06%
EPS This Year
n/a
from -0.00
EPS Next Year
n/a